Chengdu Kanghua Biological Products Co (SZSE:300841) Other Income (Expense) : ¥-92 Mil (TTM As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Chengdu Kanghua Biological Products Co Other Income (Expense)?

Chengdu Kanghua Biological Products Co's other income expense for the Chengdu Kanghua Biological Products Co's pretax income for the three months ended in Mar. 2025 was ¥-6 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-92 Mil.

Chengdu Kanghua Biological Products Co Other Income (Expense) Historical Data

The historical data trend for Chengdu Kanghua Biological Products Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Kanghua Biological Products Co Other Income (Expense) Chart

Chengdu Kanghua Biological Products Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Income (Expense)

Get a 7-Day Free Trial

0.89

263.35

11.17

-45.31

-90.98

Chengdu Kanghua Biological Products Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Income (Expense)	Get a 7-Day Free Trial															-4.86	-19.22	1.90	-68.81	-6.24

Chengdu Kanghua Biological Products Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-92 Mil.

Chengdu Kanghua Biological Products Co (SZSE:300841) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Chengdu Kanghua Biological Products Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Kanghua Biological Products Co Ltd (SZSE:300841) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 182, Beijing Road, Chengdu Economic and Technological Development Zone, Sichuan Province, Chengdu, CHN, 610100

Website

https://www.kangh.com

Chengdu Kanghua Biological Products Co Ltd is engaged in research, development, production, sales and technical services of biological products for prevention, and the existing products include Group ACYW135 Meningococcal Polysaccharide Vaccine-Maikexin, Rabies Vaccine (human diploid cell) for Human Use, freeze-dried - HDCV. The company's products include ACYW135 Meningococcal Polysaccharide Vaccine; and Rabies Vaccine.

Executives

Sun Wan Feng	Executives
Hou Wen Li	Directors, executives
Wu Wen Nian	Executives
Chen Huai Gong	Executives
Li Sheng You	Executives
Wang Qing Han	Directors, executives
Li Xiao Wen	Supervisors

Chengdu Kanghua Biological Products Co Headlines

No Headlines